Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ-PAF Study-Reference-Cited by-同舟云学术

Combined Administration of Quinidine and Propafenone for Atrial Fibrillation: The CAQ-PAF Study

Published:2012-02 Issue:2 Volume:52 Page:171-179
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

O'Hara Gilles E.,Philippon François,Gilbert Marcel,Champagne Jean,Michaud Véronique,Charbonneau Lyne,Pruneau Guylaine,Hamelin Bettina A.,Geelen Peter,Turgeon Jacques

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270011399574/fullpdf

Reference49 articles.

1. Medical management of atrial fibrillation: Future directions;Page;Heart Rhythm,2007

2. Innovative approaches to anti-arrhythmic drug therapy;Nattel;Nat Rev Drug Discov,2006

3. Epidemiology of atrial fibrillation: a current perspective;Chen;Heart Rhythm,2007

4. Pharmacologic management of atrial fibrillation: current therapeutic strategies;Levy;Am Heart J,2001

5. Pharmacotherapy of atrial fibrillation;Nemec;Expert Opin Pharmacother,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enabling P-glycoprotein inhibition in multidrug resistant cancer through the reverse targeting of a quinidine-PEG conjugate;Journal of Controlled Release;2020-01

2. The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo;Drug Design, Development and Therapy;2018-05

3. DDPH, a novel antihypertensive agent, is a potential dual inhibitor of hepatic CYP2D and CYP3A;Chemico-Biological Interactions;2016-03

4. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K+ (K2P) channels;European Journal of Pharmacology;2013-12

5. Syncope following 'pill-in-the-pocket' treatment of atrial fibrillation with propafenone plus quinidine;Heart;2011-08-22